← FDA Drug Approvals (Drugs@FDA)

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2026-05-27

Drug application

FDA Application #

ANDA219869

Application type

Abbreviated New Drug Application (Generic)

Brand name

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

Generic name

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE

Active ingredients

HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD V

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2026-05-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown